SonoCloud

DEVICE2 trials

Sponsors

Assistance Publique - Hôpitaux de Paris

Conditions

Brain TumorGlioblastomaGliomaMelanomaMetastatic Melanoma

Phase 1

Safety of BBB Opening With the SonoCloud

CompletedNCT02253212

Assistance Publique - Hôpitaux de ParisBrain Tumor, Glioblastoma, Glioma

Start: 2014-07-31End: 2018-07-31Updated: 2018-10-12

Safety and Efficacy of Sonocloud Device Combined With Nivolumab in Brain Metastases From Patients With Melanoma

Assistance Publique - Hôpitaux de ParisMelanoma, Metastatic Melanoma

Start: 2019-10-24End: 2023-07-05Target: 21Updated: 2020-08-20

Related Papers

Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial.

2024-02-2366 citations

CTNI-31. INTERIM RESULTS OF A PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF BBB OPENING WITH THE SONOCLOUD-9 IMPLANTABLE ULTRASOUND DEVICE IN RECURRENT GLIOBLASTOMA PATIENTS PRIOR TO IV CARBOPLATIN

Neuro-Oncology2020-11-011 citations

P05.05 Safety and feasibility of temporary blood-brain barrier disruption with the SonoCloud-1/3 implantable ultrasound device in recurrent glioblastoma

Neuro-Oncology2019-08-012 citations

Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma

Clinical Cancer Research2019-03-19331 citations

Blood-brain barrier disruption in humans using an implantable ultrasound device: quantification with MR images and correlation with local acoustic pressure

Journal of neurosurgery2019-02-2748 citations

Safety and preliminary efficacy data from a phase I study of an implantable low intensity pulsed ultrasound (LIPU) device for disrupting the blood-brain barrier (BBB) in patients treated by chemotherapy for recurrent glioblastoma (GBM).

Journal of Clinical Oncology2018-05-201 citations

Phase I/II study of an implantable device delivering low intensity pulsed ultrasound (LIPU) to disrupt the blood-brain barrier (BBB) followed by intravenous carboplatin chemotherapy in patients with recurrent glioblastoma (GBM).

Journal of Clinical Oncology2017-05-203 citations

Enhanced brain distribution of carboplatin in a primate model after blood-brain barrier disruption using an implantable ultrasound device.

2015-12-0831 citations